Advances in research on biomarkers associated with acute myocardial infarction : A review

Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc..

Acute myocardial infarction (AMI), the most severe cardiovascular event in clinical settings, imposes a significant burden with its annual increase in morbidity and mortality rates. However, it is noteworthy that mortality due to AMI in developed countries has experienced a decline, largely attributable to the advancements in medical interventions such as percutaneous coronary intervention. This trend highlights the importance of accurate diagnosis and effective treatment to preserve the myocardium at risk and improve patient outcomes. Conventional biomarkers such as myoglobin, creatine kinase isoenzymes, and troponin have been instrumental in the diagnosis of AMI. However, recent years have witnessed the emergence of new biomarkers demonstrating the potential to further enhance the accuracy of AMI diagnosis. This literature review focuses on the recent advancements in biomarker research in the context of AMI diagnosis.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:103

Enthalten in:

Medicine - 103(2024), 15 vom: 12. Apr., Seite e37793

Sprache:

Englisch

Beteiligte Personen:

Huang, Xuelan [VerfasserIn]
Bai, Suwen [VerfasserIn]
Luo, Yumei [VerfasserIn]

Links:

Volltext

Themen:

Biomarkers
Creatine Kinase
EC 2.7.3.2
Journal Article
Myoglobin
Review

Anmerkungen:

Date Completed 15.04.2024

Date Revised 25.04.2024

published: Print

Citation Status MEDLINE

doi:

10.1097/MD.0000000000037793

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370973593